Journal
STEM CELL RESEARCH
Volume 25, Issue -, Pages 1-5Publisher
ELSEVIER
DOI: 10.1016/j.scr.2017.08.021
Keywords
-
Funding
- Fundacio La Marato de TV3 [121330]
- Instituto de Salud Carlos III-ISCIII/FEDER [TerCel RD16/0011/0024, RETIC REDINRENRD16/0009, PT13/0001/0041, PI13/01731, PI15/01824, PI16/01998]
- Spanish Ministry of Economy and Competitiveness-MINECO [SAF2015-69706-R]
- AGAUR [2014-SGR-1460, 2014-SGR-1441, 2014-SGR-1564]
- CERCA Programme/Generalitat de Catalunya
Ask authors/readers for more resources
A skin biopsywas obtained froma 25-year-old female patientwith autosomal recessive Alport syndrome (ARAS) with the homozygous COL4A3 mutation c. 345delG, p.(P166Lfs* 37). Dermal fibroblasts were derived and reprogrammed by nucleofection with episomal plasmids carrying OCT3/4, SOX2, KLF4 LIN28, L-MYC and p53shRNA. The generated induced Pluripotent Stem Cell (iPSC) clone AS FiPS1 Ep6F-2 was free of genomically integrated reprogramming genes, had the specific homozygous mutation, a stable karyotype, expressed pluripotency markers and generated embryoid bodies which were differentiated towards the three germ layers in vitro. This iPSC line offers a useful resource to study Alport syndrome pathomechanisms and drug testing. (c) 2017 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available